Search results
Results from the WOW.Com Content Network
With three fruity flavors, FOCL CBD Gummies provide a delicious dose of pain relief and relaxation whenever and wherever you need it. Each gummy contains 25mg of premium CBD which may help ease ...
Cannabidiol (CBD) is a phytocannabinoid, one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. [17] Medically, it is an anticonvulsant used to treat multiple forms of epilepsy. [4]
Most commonly, gummy supplements are made from gelatin, cornstarch, water and sugar, along with flavorings. [7]Although gummy vitamins are the most popular type of gummy supplements, they may also be derived from herbal supplements, containing extracts from plants like ashwagandha [8] and cannabis (e.g., CBD), [9] as well as the algae-derived astaxanthin.
Cannabis edibles with CBD can decrease symptoms of psychosis and anxiety. [25] Edible oils, tinctures, pills, and gummies have been prescribed to people with cancer to potentially improve poor appetite, pain, or weight loss. [27] Cannabis edibles may be effective for muscle spasms and pain. [28]
This is sponsored content. Us Weekly is not endorsing the websites or products set forth below. The use of THC in any capacity may lead to health concerns and users should consult medical ...
The product pages for both Gentle Wave and Vigorvita CBD Gummies are both registered to an address in Reykjavik, Iceland, and calls to the registrant’s Iceland phone number were not answered.
Synthetic cannabinoids reagent testing kits have recently [as of?] become economical. It is often difficult to determine what is in these products without reagent testing because masking agents, such as tocopherol (or vitamin E acetate that causes vaping-associated pulmonary injury), eugenol, and fatty acids, are added to confound identification.
Based on a single study, oral CBD extract was rated probably ineffective in treating levodopa-induced dyskinesia in Parkinson's disease. [73] Alzheimer's disease. A 2009 Cochrane Review found insufficient evidence to conclude whether cannabis products have any utility in the treatment of Alzheimer's disease. [75]